Torrent Pharmaceuticals

Govt approves FDI worth Rs 4,000 cr in pharma sector, Torrent Pharma, Syngene get nod

The government, however, rejected proposal of drug firm Strides Arcolab to issue shares to non-resident and resident equity shareholders of Shasun Pharmaceuticals and deferred three proposals from other firms.

Centre clears 16 foreign investment proposals worth Rs 6,751 cr

Proposals of SME Capital Market Corp, IIFL Holdings, Quantam Simulators, Big India Malls and Cheekotel Venture Fund were among those rejected.

FIPB to consider Kotak Bank's FDI proposal on 28 May

India allows FDI in most of the sectors through automatic route, but in certain segments considered sensitive for the economy and security, the proposals have to be first cleared by FIPB.

SEZ developers seek more time from government to implement projects

SEZ developers and units -- including Torrent Pharmaceuticals and Zydus Technologies -- have sought more time from govt for implementing their projects.

Pharma sector registers single digit growth in 2013; regulators increase scrutiny

The Indian pharma sector, estimated to be around Rs 1.5 lakh crore, recorded single digit growth for the first time in several years on account of deeper price cuts under pricing policy and selective boycott of companies by the retailers.

Elder Pharma to focus on anti-infectives and expanding into international markets

Earlier this month, the Mumbai-based firm had announced to sell its branded formulation business, comprising 30 brands, to Torrent Pharmaceuticals for Rs 2,004 crore.

Torrent Pharmaceuticals seeks shareholders' nod to hike borrowing limit

Tata Motors is riding on premium demand but for how long?

While there are still pockets of strength for the global premium car market, most markets are slowing.

Pharma looks red-hot, MNCs renew their India love story

The spate of acquisitions seems to have picked up in the pharmaceutical space as borne out by recent acquisitions in this space.